Literature DB >> 18714004

In vivo suppression of naive CD4 T cell responses by IL-2- and antigen-stimulated T lymphocytes in the absence of APC competition.

Hiroto Inaba1, Meredith Steeves, Phuong Nguyen, Terrence L Geiger.   

Abstract

After stimulation, T cells enter a transient refractory period, promoted by IL-2, during which they are resistant to re-stimulation. We previously demonstrated that these IL-2- and Ag-stimulated refractory T cells are able to suppress the Ag-induced proliferation of naive T cells in vitro. We show here that, after adoptive transfer, these T cells are also able to suppress naive T cell proliferation in vivo. More interestingly, potently suppressive T cells can be generated directly in vivo by stimulation with Ag and supplemental IL-2. The activity of the suppressive cells is dose dependent, and the suppressor and suppressed T cells need not be restricted to the same MHC or Ag. Similar to its role in promoting T cell-mediated suppression in vitro, IL-2 is critical for the induction of suppressive activity in activated T cells in vivo. Supplemental IL-2, however, cannot overcome the suppressive activity in target T cells, indicating that suppression is not mediated by competition for this cytokine. Although the activated T cells block naive T cell proliferation, the naive cells do engage Ag and up-regulate the CD25 and CD69 activation markers after stimulation. Therefore, activated T cells stimulated in the presence of IL-2 develop MHC- and Ag-unrestricted suppressive activity. These results provide a new mechanism for competition among CD4(+) T lymphocytes, in which initial waves of responding T cells may inhibit subsequently recruited naive T cells. They further suggest a novel negative feedback loop limiting the expansion of T cell responses that may be present during vigorous immune responses or after IL-2 immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714004      PMCID: PMC2559971          DOI: 10.4049/jimmunol.181.5.3323

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  CD8 T cell competition for dendritic cells in vivo is an early event in activation.

Authors:  Richard A Willis; John W Kappler; Philippa C Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

2.  Regulation of naive T cell function by the NF-kappaB2 pathway.

Authors:  Naozumi Ishimaru; Hidehiro Kishimoto; Yoshio Hayashi; Jonathan Sprent
Journal:  Nat Immunol       Date:  2006-05-28       Impact factor: 25.606

Review 3.  Update on the application of interleukin-2 in the treatment of renal cell carcinoma.

Authors:  David F McDermott
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

4.  Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.

Authors:  Nina Oberle; Nadine Eberhardt; Christine S Falk; Peter H Krammer; Elisabeth Suri-Payer
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 5.  Regulatory T cells in experimental autoimmune disease.

Authors:  Elisabeth Suri-Payer; Benedikt Fritzsching
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

6.  Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Aixin Yu; Thomas R Malek
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Authors:  Matthew A Burchill; Jianying Yang; Christine Vogtenhuber; Bruce R Blazar; Michael A Farrar
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 8.  Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Manuela Battaglia; Rosa Bacchetta; Katharina Fleischhauer; Megan K Levings
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

9.  Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.

Authors:  Alejandro V Villarino; Cristina M Tato; Jason S Stumhofer; Zhengju Yao; Yongzhi K Cui; Lothar Hennighausen; John J O'Shea; Christopher A Hunter
Journal:  J Exp Med       Date:  2007-01-16       Impact factor: 14.307

10.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Authors:  David A Price; Jason M Brenchley; Laura E Ruff; Michael R Betts; Brenna J Hill; Mario Roederer; Richard A Koup; Steven A Migueles; Emma Gostick; Linda Wooldridge; Andrew K Sewell; Mark Connors; Daniel C Douek
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

View more
  3 in total

1.  Dynamic regulation of functionally distinct virus-specific T cells.

Authors:  Zaza M Ndhlovu; Mathias Oelke; Jonathan P Schneck; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

Review 2.  Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function.

Authors:  Terrence L Geiger; Sharyn Tauro
Journal:  Hum Immunol       Date:  2011-12-27       Impact factor: 2.850

3.  Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.

Authors:  Angelika Schmidt; Matilda Eriksson; Ming-Mei Shang; Heiko Weyd; Jesper Tegnér
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.